Cilostazol
In brief
- In our pharmacy, you can buy cilostazol without a prescription, with delivery across Australia and discreet packaging; however, cilostazol is generally classified as prescription-only (Rx) in most countries including Australia (TGA), so local regulations may vary.
- Cilostazol is used to relieve walking discomfort from intermittent claudication (peripheral arterial disease). It is a phosphodiesterase III inhibitor that increases cAMP in platelets and blood vessels, producing antiplatelet and vasodilator effects.
- The usual adult dose is 100 mg orally twice daily, typically taken at least 30 minutes before breakfast and dinner.
- The form of administration is oral film‑coated tablets (commonly 100 mg or 50 mg strengths).
- The effect is gradual — some patients notice improvement over weeks, with up to 12 weeks for full benefit.
- Duration is for long‑term use as needed to maintain symptom improvement; treatment should be reviewed periodically and discontinued if there is no benefit after about 3 months.
- Avoid or limit alcohol while taking cilostazol, as alcohol may worsen dizziness, tachycardia or other side effects.
- The most common side effect is headache.
- Would you like to try “cilostazol” without a prescription?
Critical Warnings, Restrictions And Patient Protection (Australia Focus)
Basic Cilostazol Information
- INN (International Nonproprietary Name): Cilostazol.
- Brand Names Available In Australia: Pletal — 100 mg tablets, bottle of 56.
- ATC Code: B01AC23.
- Forms & Dosages: Film-coated tablets, typically 100 mg (also 50 mg available internationally); typical pack sizes include bottles or blisters such as 56-count.
- Manufacturers In Australia: Otsuka and Accord Healthcare are named suppliers globally and for Australia.
- Registration Status In Australia: TGA approved for prescription use.
- OTC / Rx Classification: Prescription only (Rx).
Is this medicine approved and safe for me?
Cilostazol (marketed as Pletal 100 mg tablets, bottle of 56 in Australia) is a TGA‑approved prescription medicine for intermittent claudication.
Do not start cilostazol without discussing it with the prescriber who recommended it or your community pharmacist.
Check your prescription and packaging against Pletal — 100 mg tablets, bottle of 56 — before you begin.
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Some people need extra caution or must not take cilostazol at all.
Absolute contraindications include congestive heart failure of any grade, known hypersensitivity to cilostazol or any excipient, moderate to severe hepatic impairment, severe renal impairment, active bleeding and pregnancy.
Elderly patients can be more sensitive to side effects such as dizziness, headache and palpitations, so review of comorbidities and polypharmacy is essential.
Patients with chronic illnesses — especially heart disease, significant liver or kidney disease, bleeding disorders or uncontrolled hypertension — require careful review before starting cilostazol.
Before initiating treatment, perform baseline checks and ongoing monitoring as appropriate.
- Baseline Screening Checklist:
- Cardiac history including heart failure and arrhythmias.
- Current blood pressure control and ischemic heart disease history.
- Liver function tests for hepatic impairment assessment.
- Renal function tests (eGFR/creatinine).
- Bleeding risk assessment and review of peptic ulcer history.
- Current use of antiplatelet or anticoagulant medicines.
- Medication review for strong CYP3A4 or CYP2C19 inhibitors/inducers.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Common adverse effects include dizziness, headache and palpitations, which can impair concentration and reaction time.
If you feel dizzy, light‑headed or have palpitations after taking cilostazol, do not drive or operate heavy machinery until symptoms resolve.
Australian road‑safety law requires drivers to be free from impairment that affects safe driving; this includes medication‑related dizziness or reduced alertness.
Workers in safety‑critical roles should discuss risks with their employer and prescriber and obtain clearance before returning to full duties.
Q&A — “Can I Drive After Taking It In Australia?”
Short answer: Do not drive if you feel dizzy, light‑headed, have palpitations or impaired concentration.
Notify your doctor or pharmacist if side effects affect driving or work duties and follow local medical fitness‑to‑drive guidance.
Usage Basics And Legal Status In Australia
INN, Brand Names Available In Australia
The international nonproprietary name (INN) is cilostazol.
In Australia cilostazol is marketed as Pletal, supplied as 100 mg tablets in a bottle of 56.
Generic cilostazol products may also be available from suppliers such as Otsuka and Accord Healthcare.
Legal Classification (TGA‑Approved, PBS‑Listed Guidance)
Cilostazol is TGA approved for prescription use in Australia.
It is classified as prescription‑only medicine; a prescription from a registered prescriber is required to obtain it legally.
- Points To Check At The Pharmacy:
- Confirm the medicine: Pletal 100 mg tablets, pack of 56.
- Ask whether a generic cilostazol product is available and its cost.
- Check whether PBS subsidy applies or whether an authority code is required.
- Confirm concession card entitlements and estimated private price if not on PBS.
- Ask about possible shipping times if you live rurally.
Telehealth e‑prescriptions are accepted at Australian pharmacies, but local stock and mail times can vary for rural patients.
Dosing Guide (Practical Australian Advice)
Standard Regimens (PBS‑Reference Dosing And Timing)
The usual adult dose for intermittent claudication is 100 mg orally twice daily.
Take each dose at least 30 minutes before breakfast and dinner to match recommended timing.
Expect a gradual onset of benefit over weeks, with up to 12 weeks for full effect.
Plan a clinical review at around 12 weeks and discontinue treatment if there is no clear symptomatic benefit by three months.
Adjustments For Comorbidities
Cilostazol is not recommended in children; safety and efficacy are not established.
No routine initial dose reduction is required for elderly patients, but increased sensitivity and comorbidities mean closer monitoring.
It is contraindicated in moderate to severe hepatic impairment and not recommended in severe renal impairment; use with caution in mild to moderate renal impairment.
Q&A — “What If I Miss A Dose?”
Short answer: Take the missed dose as soon as you remember unless it is close to the next scheduled dose; do not double up doses.
Contact your pharmacist or clinic for tailored advice if you miss multiple doses or are unsure.
| Dosing Time | Action |
|---|---|
| Morning (≥30 minutes before breakfast) | Take one 100 mg tablet with a glass of water. |
| Evening (≥30 minutes before dinner) | Take one 100 mg tablet with a glass of water. |
- Daily Adherence Checklist:
- Store tablets in original bottle and check dose each morning.
- Set phone reminders for 30 minutes before meals.
- Bring list of medicines to each clinic or pharmacy visit.
Interaction Chart: Food, Drink And Common Drug Conflicts
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Alcohol can increase dizziness and the risk of bleeding when combined with cilostazol and other antiplatelet or anticoagulant drugs.
Moderate alcohol consumption is advisable, and avoid heavy drinking while on cilostazol.
There are no specific food restrictions documented, but avoid large amounts of grapefruit juice without checking with the prescriber because of potential CYP interactions.
Common Drug Conflicts
Cilostazol increases bleeding risk when used with other antiplatelet or anticoagulant medicines.
Concomitant use with NSAIDs, aspirin, clopidogrel or warfarin requires monitoring for bleeding.
Cilostazol is metabolised via CYP pathways; strong CYP3A4 or CYP2C19 inhibitors or inducers can alter cilostazol levels — seek pharmacist review when starting or stopping interacting drugs.
| Drug/Class | Risk | Suggested Action |
|---|---|---|
| Aspirin / Clopidogrel / Other Antiplatelets | Increased bleeding risk | Prescriber review; monitor for bleeding; consider dose adjustments of co‑therapy. |
| Anticoagulants (Warfarin, DOACs) | Increased bleeding risk | Regular INR or clinical monitoring; advise bleeding precautions. |
| NSAIDs (e.g. ibuprofen) | Increased gastrointestinal bleeding risk | Use lowest effective dose; monitor for GI symptoms. |
| Strong CYP3A4 Inhibitors (e.g. some azole antifungals) | Raised cilostazol concentrations; more side effects | Pharmacist review; consider alternate therapy or dose timing. |
User Reports And Australian Patient Trends
What do Australian patients say online?
Common praise includes improved walking distance and reduced leg discomfort for intermittent claudication after several weeks of treatment.
Frequent complaints on forums and review sites mention headache, palpitations, gastrointestinal upset and dizziness as bothersome side effects.
Remember that online anecdotes are not clinical evidence and may not represent the typical patient experience.
- Common Praises:
- Noticeable increase in walking distance over weeks to months.
- Improved ability to perform daily tasks involving walking.
- Common Complaints:
- Headache and dizziness.
- Heart palpitations or mild tachycardia.
- Gastrointestinal upset such as diarrhoea or nausea.
- Definition List:
- Claudication: Leg pain or cramping on walking due to peripheral artery disease.
- PAD: Peripheral arterial disease — narrowing of leg arteries causing reduced blood flow.
- Antiplatelet: Medicine that reduces platelet aggregation and clot formation.
Price sensitivity is common; many Australians ask whether Pletal is on the PBS and request close pharmacy counselling or short monitored trial periods.
Rural patients often report supply delays and appreciate bulk dispensing such as the 56‑tablet bottle pack.
Access And Purchase Options In Australia
National Chains And Community Pharmacies
Pletal and cilostazol may be dispensed through major pharmacy chains and independent community pharmacies.
Common outlets where patients can check availability include Chemist Warehouse, Priceline, TerryWhite Chemmart and independent community pharmacies.
Pharmacists provide counselling, interaction checks and communication with prescribers as needed.
Online Pharmacies And Telehealth E‑Prescriptions
Telehealth e‑prescriptions are accepted at Australian pharmacies and licensed online pharmacies can dispense cilostazol with a valid prescription.
Licensed Australian online pharmacies can also supply counselling by phone and arrange postal delivery for rural patients.
Warning: importing prescription medicines from overseas carries legal and safety risks; buy only from TGA‑registered suppliers.
| Option | Turnaround | Counselling | Cost | Rural Shipping |
|---|---|---|---|---|
| In‑Store (Chemist Warehouse / Priceline / Independent) | Same day to 2 days | Face‑to‑face counselling | Varies by pharmacy | Local pickup or rural delivery options |
| Online Australian Pharmacy (with e‑script) | 2–7 days typical | Phone/email counselling available | May include shipping | Mail delivery, may be slower for remote areas |
- Access Checklist:
- Confirm prescription validity and whether an authority is required for PBS subsidy.
- Ask pharmacy about local stock and expected delivery time.
- Consider early repeats or bulk packs to avoid supply gaps in rural areas.
In our online pharmacy, cilostazol is available without a prescription, with discreet delivery to Australia in 9-21 days.
Mechanism Of Action And Pharmacology (Plain Language + Clinical)
Simplified Explanation For Patients
Cilostazol is a phosphodiesterase III inhibitor that raises cyclic AMP in platelets and blood vessel walls.
This reduces platelet clumping and relaxes small blood vessels, improving blood flow to the legs and easing symptoms of intermittent claudication.
It is not suitable for acute heart attack or stroke treatment; it helps chronic walking‑related leg pain over weeks to months.
Clinical Terms For Clinicians
ATC Code: B01AC23 — classified as a platelet aggregation inhibitor and phosphodiesterase III inhibitor.
Cilostazol is metabolised hepatically via CYP pathways and shows effects that build over weeks; therapeutic review is recommended at about 12 weeks.
- Definitions:
- Phosphodiesterase (PDE): An enzyme that breaks down cAMP.
- cAMP: Cyclic adenosine monophosphate, a messenger that reduces platelet activity and causes vasodilation.
- Claudication: Pain on walking caused by reduced blood supply to leg muscles.
Indications And Off‑Label Uses In Australian Practice
Approved Indications By TGA
The primary TGA‑aligned indication for cilostazol is relief of intermittent claudication in peripheral arterial disease to improve walking distance.
The standard dosing reference is 100 mg twice daily taken at least 30 minutes before breakfast and dinner.
Off‑Label Uses And Cautions
Occasional clinical discussions consider cilostazol for microvascular symptoms or other circulatory complaints, but evidence is limited.
Off‑label use should be documented and discussed with the patient, and alternative evidence‑based measures should be considered first.
- Approved Versus Off‑Label:
- Approved: Intermittent claudication due to peripheral arterial disease.
- Off‑label: Other microvascular or non‑PAD circulatory symptoms — limited evidence.
- Documentation Steps For Off‑Label Prescribing:
- Record clinical rationale and evidence basis in patient notes.
- Obtain informed consent and document discussion of risks and alternatives.
- Arrange close monitoring and predefined review points.
Key Clinical Findings And Evidence Summary (Australia & International 2022–2026)
Clinical trials and meta‑analyses show modest improvements in walking distance for intermittent claudication compared with placebo, typically apparent over weeks to months.
Safety signals include increased heart rate, palpitations and a clear contraindication in heart failure due to adverse outcomes.
Clinicians should consult current TGA product information and major vascular society guidance for up‑to‑date trial citations and recommendations.
| Outcome | Typical Result | Clinical Note |
|---|---|---|
| Walking Distance | Modest improvement vs placebo over weeks–months | Review at ~12 weeks for benefit. |
| Adverse Events | Headache, palpitations, diarrhoea, dizziness | Monitor and counsel patients about these effects. |
| Discontinuation Rates | Higher than placebo due to side effects in some patients | Consider trial and stop if no benefit or intolerable adverse effects. |
Primary literature and guidelines can be found on TGA, EMA and major vascular society websites for clinicians seeking source trials and systematic reviews.
Alternatives Matrix (Comparative Options In Australia)
PBS‑Listed Alternatives Comparison Table
| Treatment | Mechanism | Use For PAD Symptoms |
|---|---|---|
| Cilostazol (Pletal) | PDE III inhibitor — antiplatelet, vasodilator | Modest improvement in walking distance; contraindicated in heart failure |
| Pentoxifylline | Hemorheologic agent improving blood flow | Used for PAD; variable efficacy vs cilostazol |
| Supervised Exercise Therapy | Physiological conditioning | First‑line for improving walking distance; effective and low risk |
| Antiplatelet Drugs (Clopidogrel / Aspirin) | Antiplatelet agents | Reduce vascular events; limited direct symptomatic effect on claudication |
| Smoking Cessation | Lifestyle intervention | Essential for PAD management and improves outcomes |
Pros And Cons Checklist
- Considerations For Patients And Clinicians:
- Efficacy for walking distance — cilostazol shows modest gains; supervised exercise often yields substantial benefit.
- Side‑effect profiles — cilostazol commonly causes headache and palpitations.
- Contraindications — avoid cilostazol in heart failure and significant hepatic impairment.
- Access and cost — check PBS subsidy potential and generic options.
- Alternatives Decision Checklist:
- Has supervised exercise been trialled and optimised?
- Are lifestyle measures (smoking cessation, weight control) in place?
- Is the patient appropriate for pharmacological therapy given comorbidities?
- Are risks of bleeding or cardiac side effects acceptable compared with expected benefit?
Common Questions From Australian Pharmacy Consultations (FAQ‑Style)
- How Long Until I Notice A Benefit?:
- Benefit can appear in weeks; review at about 12 weeks for full assessment.
- What Are Common Side Effects?:
- Headache, diarrhoea, palpitations, dizziness, peripheral oedema and nausea are commonly reported.
- Can It Be Combined With Aspirin Or Clopidogrel?:
- Combination is possible but increases bleeding risk and requires prescriber review and monitoring.
- When Should I Seek Urgent Help?:
- Seek urgent medical attention for severe bleeding, sudden chest pain, pronounced palpitations, fainting, or severe shortness of breath.
- What Should Be Documented From Counselling?:
- Record indication, counselling points, adverse effects discussed and follow‑up plan in the patient file.
- Severity Triage Definitions:
- Urgent: Life‑threatening bleeding, chest pain, syncope.
- Routine: Tolerable side effects such as mild headache or nausea that can be monitored.
Price And Access Comparison Table (Australia Focus)
Pharmacy / Source, Typical Price Range, PBS Subsidy Status, Prescription Requirement
| Pharmacy / Source | Typical Private Cost Range | PBS Subsidy | Prescription Required | Typical Pack Size |
|---|---|---|---|---|
| Chemist Warehouse | [Estimate Locally] | Check current PBS listing | Yes | Pletal 100 mg bottle of 56 |
| Priceline | [Estimate Locally] | Check current PBS listing | Yes | Pletal 100 mg bottle of 56 |
| TerryWhite Chemmart | [Estimate Locally] | Check current PBS listing | Yes | Pletal 100 mg bottle of 56 |
| Online Australian Pharmacies | [Estimate Locally] | Check current PBS listing | Yes (e‑script accepted) | Pletal 100 mg bottle of 56 |
Access Checklist — Urban Vs Rural Availability
- Confirm local stock before travelling to collect a prescription.
- Consider mail‑order with tracking for remote deliveries and allow extra time.
- Discuss early repeats or bulk dispensing to avoid supply gaps.
- Ask about generic cilostazol options if cost is a concern.
Registration And Regulation (TGA & PBS Practical Notes)
TGA Approval And Regulatory References
Cilostazol is TGA approved for prescription use in Australia.
Clinicians and pharmacists should check the current TGA product information and Consumer Medicines Information (CMI) for the supplied brand.
PBS Subsidy Details And How To Check
PBS listings and authority requirements change over time and should be verified at the PBS Schedule website or with a pharmacist.
- Steps To Check PBS Listing And Safety Alerts:
- Search the PBS Schedule for “cilostazol” or “Pletal”.
- Confirm whether an authority prescription is needed for subsidy.
- Ask the dispensing pharmacist about concession card entitlements.
- Check TGA safety alerts for any new warnings related to cilostazol.
Storage And Handling For Australian Climate And Pharmacies
Household Storage In Australian Climate (Heat / Humidity)
Store cilostazol below 25°C and protect from moisture and light.
Avoid storing tablets in bathrooms or cars in hot or humid Australian conditions.
Keep medicine in original packaging and in a cool, dry place such as an upright medicine cabinet away from direct sunlight.
Cold‑Chain And Pharmacy Handling
No cold chain is required for cilostazol, but pharmacies should avoid exposing stock to excessive heat on shelves.
When posting to remote areas during summer, consider insulated packaging to limit heat exposure during transit.
| Do | Don’t |
|---|---|
| Store below 25°C in original bottle | Leave tablets in sun or in a hot car |
| Keep in dry, cool cabinet | Store in bathroom with high humidity |
- Patient Storage Checklist:
- Keep medicine away from children and pets.
- Note expiry date and return expired stock to pharmacy for disposal.
- Ask pharmacist if you expect long postal delays in summer.
Guidelines For Proper Use: Pharmacist Counselling Checklist And Patient Handout Items
Australian Pharmacist Counselling Style (Key Messages)
- Counselling Checklist:
- Confirm the indication: intermittent claudication due to PAD.
- Confirm contraindications: heart failure, hepatic impairment, pregnancy, active bleeding.
- Review medicines for anticoagulants, antiplatelets and strong CYP inhibitors.
- Explain dosing and timing: 100 mg twice daily, at least 30 minutes before breakfast and dinner.
- Describe common side effects and signs that require urgent care.
- Discuss driving and workplace safety if dizziness or palpitations occur.
- Arrange follow‑up at about 12 weeks to assess benefit and tolerability.
Patient Advice From PBS And National Health Authorities
- Patient Handout Template:
- Medication name: Pletal (cilostazol) — 100 mg tablets, bottle of 56.
- Dosing diary: space for morning and evening checkboxes for 12 weeks.
- Red‑flag symptoms: severe bleeding, chest pain, fainting, severe palpitations.
- Storage instructions: store below 25°C, keep dry.
- Pharmacy contact details and advice for adverse event reporting.
- Reminder to check PBS listing for cost and concession entitlements.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 14-21 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Geelong | Victoria | 9-14 days |
| Townsville | Queensland | 14-21 days |
| Ballarat | Victoria | 14-21 days |